CAS: 530-62-1; Di(1H-Imidazol-1-yl)Methanone

相似化合物

84661-56-3 6160-65-2 104619-51-4

上下游产品

CAS号288-32-4 咪唑 | CAS号75-44-5 光气 | CAS号32315-10-9 三光气 | CAS号6309-30-4 1-Butanamine,N,... | CAS号503-38-8 氯甲酸三氯甲酯 | CAS号74731-19-4 imidazole-1-car... | CAS号18156-74-6 三甲基硅咪唑(TSIM) | CAS号10364-93-9 imidazol-1-yl-(... | CAS号107659-85-8 (4S,5R)-5-butyl... | CAS号107659-80-3 (4S,5R)-4-(2,4-... | CAS号107659-83-6 (4S,5R)-4-(4-ch... | CAS号107659-79-0 (4S,5R)-5-(2,4-... | CAS号1075753-25-1 5-氯-6-氟-2,3-二氢-... | CAS号107741-31-1 (4S,5R)-4,5-bis... | CAS号107679-95-8 (4S,5R)-4-(2,4-... | CAS号105601-20-5 3-(1-(二甲基氨基)乙基)... | CAS号107659-75-6 (4S,5R)-4,5-bis...

咪唑,光气置于正丁基锂体系中,用 四氢呋喃 作为反应溶剂,化学反应 2.0H,以5.9 G的收率获得产物n,N'-羰基二咪唑
参考文献:新型亚胺桥接咪唑配体的多螯合非金属茂络合物促进乙烯与1-己烯的共聚
标题:新型亚胺桥接咪唑配体的多螯合非金属茂络合物促进乙烯与1-己烯的共聚
摘要:一系列新颖的桥连多螯合非茂金属催化剂是由处理的合成n,N-咪唑,N,N--Dimethylimidazole,和n,N-苯并咪唑与ñ正丁基锂,2,6-二甲基苯胺,和mcl 4(m = Ti,Zr)在thf中的溶液.这些催化剂被甲基铝氧烷(mao)活化后,用于乙烯与1-己烯的共聚.详细研究了聚合温度,Al / M摩尔比和单体压力对乙烯共聚行为的影响.这些结果表明,这些催化剂有利于乙烯与1-己烯的共聚,具有高催化活性和高共聚单体掺入率.共聚物的特点是13C NMR,Waxd,Gpc和dsc.结果证实,所获得的共聚物具有约33-35的宽分子量分布(mwd)和高达9.2 Mol%的1-己烯高掺入量,共聚物的熔融温度取决于共聚物链中1-己烯的掺入量和共聚物链中的1-己烯单元被乙烯单元隔离.乙烯均聚物的mwd范围更广,为42-46.©2009 Wiley Periodicals,Inc. J Polym
DOI:10.1002/pola.23800

专利信息

专利号:WO-2021014395-A1
优先权日:2019-07-24
标题:Process for the synthesis of deuterated capsaicin, capsaicinoids and synthetic capsaicin analogs
发明人：ORUGANTI SRINIVAS; AMRUTAPU SRAVANTH KUMAR; SAMPATH MAGESH; SEN SAIKAT
权利人:DR REDDY’S INST OF LIFE SCIENCES
摘要:The present application provides novel processes for the synthesis of deuterated intermediates of capsaicinoids, particularly II, III, IV and V of capsaicinoids, relating to pharmaceutical applications. The invention also provides novel intermediates of compounds of formula IX, XIV, XV, XVI, XVII, XVIII, XX and XXI utilized in the process of making deuterated capsaicin II, III, IV and V.

专利号:US-2004152905-A1
优先权日:2003-01-31
标题:Universal building blocks and support media for synthesis of oligonucleotides and their analogs
发明人：GUZAEV ANDREI P; MANOHARAN MUTHIAH
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and chemically modified oligonucleotide analogs, are provided. In addition, methods for functionalization of a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-11891351-B2
优先权日:2020-03-20
标 题 :Synthesis of capsaicin derivatives
发明人：LAGER ERIK
权利人:AXICHEM AS
摘要:The present invention relates to the synthesis of capsaicin derivatives, specifically to the synthesis of 6-heptyne derivatives of capsaicin.

专利号:US-11274081-B2
优先权日:2016-05-30
标 题:Process for the synthesis of ivacaftor
发明人：REDDY DUMBALA SRINIVASA; KULKARNI AMOL ARVIND; NATARAJAN VASUDEVAN; SHARMA MRITYUNJAY KESHAVPRASAD
权利人:COUNCIL SCIENT IND RES
摘要:The present disclosed an improved process for the synthesis of ivacaftor starting from indole acetic acid ester which can be performed in batch as well as continuous flow synthesis. The present invention further disclosed to a continuous process for the synthesis of compound of formula (II) or formula (III) from compound of formula (I) in continuous flow reactor.

专利号:WO-2009152051-A1
优先权日:2008-06-12
标题:Synthesis of a macrocyclic hcv protease inhibitor
发明人：WANG PENG
权利人:PHENOMIX CORP; WANG PENG
摘要:The present invention provides a method of synthesis of a macrocyclic compound known as a potent inhibitor of a protease produced by the hepatitis C virus (HCV). Inhibition of the viral protease blocks assembly of mature viral particles in an infected mammalian host. The method of synthesis involves a ring-closing metathesis step using a ruthenium catalyst. Hydrogenation and boronate deprotection provide the HCV protease-inhibitory product.

专利号:US-7220776-B2
优先权日:2003-06-30
标题:Method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
发明人：DUBUFFET THIERRY; LECOUVE JEAN-PIERRE
权利人:SERVIER LAB
摘要:Process for the synthesis of perindopril of formula (I): n nand its pharmaceutically acceptable salts.